Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Affimed N.V. (AFMD)

Affimed N.V. (AFMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Affimed N.V. Reports Promising 40% Complete Remission Rate for AFM28 in Heavily Pretreated R/R AML Patients Quiver Quantitative, Inc. - Mon Dec 9, 10:42PM CST

AFM28 shows 40% complete remission rate in R/R AML patients with manageable safety profile in Phase 1 trial.Quiver AI SummaryAffimed N.V. announced promising results for its bispecific innate cell engager,...

AFMD : 1.1900 (+0.85%)
Affimed N.V. Reports Encouraging Efficacy of Acimtamig Combined with AlloNK® in R/R Classical Hodgkin Lymphoma at ASH Annual Meeting Quiver Quantitative, Inc. - Sun Dec 8, 9:22PM CST

Acimtamig with AlloNK® shows 86% response rate in relapsed/refractory classical Hodgkin lymphoma, with manageable safety.Quiver AI SummaryAffimed N.V. announced promising results from a study combining...

AFMD : 1.1900 (+0.85%)
AFMD Stock Down Despite FDA's RMAT Status for Lymphoma Therapy
AFMD Stock Down Despite FDA's RMAT Status for Lymphoma Therapy Zacks Investment Research - Fri Dec 6, 10:42AM CST

Affimed N.V. AFMD announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to its pipeline candidate, acimtamig (AFM13).The regulatory body granted the RMAT designation...

AFMD : 1.1900 (+0.85%)
CSTL : 27.53 (+1.62%)
SPRO : 0.9551 (-4.30%)
ARTV : 11.11 (+11.10%)
Affimed Receives FDA RMAT Designation for Acimtamig and Artiva’s AlloNK® in Relapsed/Refractory Hodgkin Lymphoma Treatment Quiver Quantitative, Inc. - Thu Dec 5, 3:44PM CST

Affimed's acimtamig and Artiva's AlloNK® receive FDA RMAT designation for treating relapsed/refractory Hodgkin Lymphoma based on promising early data.Quiver AI SummaryAffimed N.V. announced that the U.S....

AFMD : 1.1900 (+0.85%)
Affimed N.V. Completes Enrollment in NSCLC Cohort and Prepares for Data Presentations at ASH 2024 Quiver Quantitative, Inc. - Thu Nov 14, 4:00PM CST

Affimed N.V. reports on clinical trials, financial results, and updates on cash position through Q4 2025.Quiver AI SummaryAffimed N.V. announced the completion of enrollment in the EGFR wild-type non-small...

AFMD : 1.1900 (+0.85%)
Affimed N.V.: Q3 Earnings Snapshot AP - Thu Nov 14, 5:38AM CST

Affimed N.V.: Q3 Earnings Snapshot

AFMD : 1.1900 (+0.85%)
Affimed N.V.: Q2 Earnings Snapshot AP - Thu Sep 5, 5:46AM CDT

Affimed N.V.: Q2 Earnings Snapshot

AFMD : 1.1900 (+0.85%)
Affimed N.V.: Q1 Earnings Snapshot AP - Wed Jun 12, 5:41AM CDT

Affimed N.V.: Q1 Earnings Snapshot

AFMD : 1.1900 (+0.85%)
Affimed N.V.: Q3 Earnings Snapshot AP - Tue Nov 14, 2023

Affimed N.V.: Q3 Earnings Snapshot

AFMD : 1.1900 (+0.85%)
Affimed N.V.: Q2 Earnings Snapshot AP - Thu Aug 10, 2023

Affimed N.V.: Q2 Earnings Snapshot

AFMD : 1.1900 (+0.85%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot